Dataset ID: 25

Back to List

Dataset Details

Study Design
Study Design Background
Preclinical study on SOD1-G93A ALS mice assessing skeletal muscle inflammation and mitochondrial dysfunction through [18F]DPA-714 PET/CT imaging, supported by immunohistochemistry, confocal microscopy, and immunofluorescence.
Study Description
This study explores the role of skeletal muscle inflammation and mitochondrial dysfunction in amyotrophic lateral sclerosis (ALS) using the SOD1-G93A mouse model. PET/CT imaging with [18F]DPA-714 was performed to assess TSPO expression in the triceps brachii at different disease stages. Histological analyses, including immunohistochemistry and confocal microscopy, validated PET findings and characterized cellular and molecular changes in muscle tissues.
Study Type
Preclinical
Study Subtype
In vivo
Publication
Paper Linked
Yes
Paper Title
TSPO Expression and [18F]DPA-714 PET/CT Imaging as Pathogenetic and Diagnostic Biomarkers in Symptomatic Stages of Skeletal Muscle Fiber Degeneration in SOD1-G93A ALS Mice
Paper Authors
Anzilotti Serenella, De Iesu Nunzia, Gargiulo Sara, Di Muraglia Noemi, Cicatiello Annunziata Gaetana, Dentice Monica, Panico Mariarosaria, Albanese Sandra, Annunziato Lucio, Salvatore Marco, Pignataro Giuseppe, Pappatà Sabina
Affiliation
1. Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy. 2. IRCCS SYNLAB SDN, Naples, Italy Siena, Italy. 3. Division of Pharmacology, Department of Neuroscience, School of Medicine, University of Naples “Federico II”, Naples, Italy. 4. Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, Italy 5. Institute of Biostructures and Bioimaging, National Research Council, Naples, Italy
Paper Journal
The FASEB Journal
Paper Year
2025
Paper DOI
Open Access
Yes
Study Component
Multi Modality Images
Yes
Imaging Modality
PET/CT
Imaging Sub Modality
18F
Radiation
Yes
Imaging Coverage
Skeletal muscles
Imaging Target
Inflammation
Dataset Information
Institution
IRCCS SYNLAB SDN, Naples, Italy
PI
Sabina Pappatà
Country Of Institution
Italy
Imaging Facility
Prelinical Imaging Facility, Ceinge Biotecnologie Avanzate scarl
Country Of Imaging Facility
Italy
Link To Dataset
Internal server
Funding
Yes
Dataset Access
Limited
DUO Data Use Permission
DUO Data Use Modifier
DUO Investigation
Contact Person
In Vivo Experimental Parameters
Number Of Groups
2
Types Of Groups
SOD1-G93A , WT
Overall Sample Size
18
Main Disease Category
Disease of anatomical entity
Specific Disease Model
Neurological
Organ Or Tissue
Skeletal muscles, brain
Sample Size For Each Group
6 SOD1-G93A mice, 6 wt mice
Randomization
No
Blinding
No
Species
Strain
C57BL/6J (SOD1-G93A transgenic)
Immune Status
Immunocompetent
Sex
Male
Age
6 weeks old
Weight
20 g
Genotype
Heterozygous
Genetic Manipulation
Transgenic overexpression
Gene
SOD1
Experimental Procedures
Pharmacological Procedures Intervention And Control
No
Blood Sampling
No
Surgical Procedures Including Sham Surgery
No
Pathogen Infection Intervention And Control
No
Analgesic Plan To Relieve Pain Suffering And Distress
No
Anesthesia For Imaging
Yes
Anesthesia Type
Gas
Anesthesia Drugs
Isovet
Anesthesia Dose
Induction- 3–4% isoflurane in O₂ ; Maintenance- 1–2% in O₂
Euthanasia
Yes
Method
Anesthetic overdose
Histology
Yes
Tissues Collected Post Euthanasia
Triceps brachii skeletal muscle
Imaging
Yes
Frequency Of Imaging
One time
Timing Of Imaging
1 week from disease onset
Contrast Agent Or Radio Isotope Or Challenge With Gas Molecule
Yes
Contrast Agent Chemical Drug
[¹⁸F]DPA-714
Contrast Agent Dose
200–800 GBq/μmol
Injection Volume
150 µL
Route Of Administration
Intravenous
Cell Lines
No
Cell Line
No
Provenance
No
Image Acquisition
Instrument Vendor
Sedecal
Instrument Type
SuperArgus
Instrument Specifics
Fov 47 mm (axial) × 60 mm (transaxial)
Image Data
Image Type
Processed image
Image Scale
SUV
Format Compression
DICOM
Dimensions
2D
Image Processing Methods
Image recontruction
Image Reconstruction Algorithm
OSEM
Analyzed Data
Data Used For Analysis
SUV
Updated Year
2025